In today's world, Dokumeds is a topic that arouses interest and debate in different areas. From politics to technology, Dokumeds has captured the attention of millions of people around the world, generating passionate discussions and conflicting opinions. Whether due to its impact on society, its historical relevance or its influence on people's daily lives, Dokumeds has become a central topic in current conversations. In this article, we will explore different aspects related to Dokumeds, from its origins to its possible consequences, with the aim of offering a broad and complete vision of this phenomenon that intrigues us so much.
Company type | Private |
---|---|
Industry | |
Founded | 1995 |
Headquarters | Riga, Latvia |
Services | Support services for pharmaceutical, biotech and medical companies |
Revenue | 8,307,219 euro (2022) ![]() |
867,980 euro (2022) ![]() | |
Total assets | 5,032,347 euro (2022) ![]() |
Number of employees | 63 (2022) ![]() |
Website | www |
DOKUMEDS is European Clinical Research Organization (CRO) providing a comprehensive range of services for clinical research, focused primarily on Phase I-IV clinical trials and development for pharmaceutical, biotechnology and medical device industries. Established in 1995, Dokumeds has been expanding its coverage and services significantly over 25 years of operations. Gradual geographical and operational coverage expansion has correlated with company staff growth and lowering of employee turnover.[citation needed] Nowadays Dokumeds is a leading international CRO with operational capabilities in 30+ countries in Europe, Africa, and other regions.
Apart from a full cycle of services for Phase I – IV clinical development programs, Dokumeds functional service provision capabilities include:[citation needed]
DOKUMEDS has offices in:
DOKUMEDS has been operating in the field of clinical trials for 25 years, founded in 1995.[1][2] Headquartered in Riga, Latvia, I was acquired by Rho in 2021.[3]